SCHEMBL30765602

SCHEMBL30765602

C[C@@H](Nc1nnc(-c2ccccc2F)n(CC(=O)O)c1=O)c1ccc2oc3ccccc3c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR139 Q6DWJ6 2/20 0.37
MEN1 O00255 1/20 0.36
GBA1 P04062 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP2C9 P11712 2/20 0.35
PTGDR Q13258 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
KDM4E B2RXH2 1/20 0.34
TSHR P16473 1/20 0.34
HTT P42858 1/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
ALOX15 P16050 1/20 0.34
MAPT P10636 1/20 0.34
SOS1 Q07889 2/20 0.33
HCRTR1 O43613 3/20 0.33
HCRTR2 O43614 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30766068 0.89 GPR139 (0.34) GPR139MEN1GBA1KMT2ACYP2C9
SCHEMBL30765685 0.87 GAA (0.41) GPR139MEN1KMT2ACYP2C9KDM4E
SCHEMBL30766151 0.87 ELANE (0.37) GPR139CYP2C9PTGDRPTGDR2HSP90AA1
SCHEMBL31558425 0.86 MEN1 (0.36) GPR139MEN1GBA1KMT2ACYP2C9
SCHEMBL31558470 0.82 LMNA (0.37) GPR139MEN1KMT2ACYP2C9PTGDR
SCHEMBL30765981 0.82 LMNA (0.37) GPR139MEN1KMT2ACYP2C9PTGDR
SCHEMBL30765751 0.81 F3 (0.34) GPR139KDM4ETSHRLMNATP53
SCHEMBL30765745 0.80 ELANE (0.37) CYP2C9PTGDRPTGDR2HSP90AA1HSP90AB1
SCHEMBL30765454 0.80 ELANE (0.37) GPR139CYP2C9PTGDRPTGDR2HTT
SCHEMBL31558409 0.78 POLB (0.36) CYP2C9HSP90AA1HSP90AB1KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568666-A1 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS Alexion Pharmaceuticals, Inc. (US) 2025-06-18 EP disclosed
CN-119768164-A Pharmaceutical compounds for treating complement-mediated disorders 阿雷克森制药公司 2025-04-04 CN disclosed
WO-2024035686-A1 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS ALEXION PHARMACEUTICALS, INC. (US) 2024-02-15 WO disclosed